Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orbis Medicines ApS
APS
Active
Advertising protection
CVR 42715646
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
27 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Orbis Medicines ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-4M
-9M
-13M
-17M
-15M
2022
-26M
2023
-52M
2024
EBITDA
DKK millions
0M
-16M
-33M
-49M
-65M
-15M
2022
-26M
-73%
2023
-52M
-100%
2024
Income statement
DKK thousands
Item
2022
2023
2024
Gross profit
-15.220
-25.596
-51.629
Staff expenses
-140
-0
-493
EBITDA
-15.360
-25.596
-52.122
Depreciation & amort.
-0
-0
-0
EBIT
-15.360
-25.596
-52.122
Net financials
899
2.093
3.597
Profit before tax
-14.461
-23.503
-48.526
Tax
-3.411
-5.865
-11.505
Net profit
-11.049
-17.638
-37.021
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
28.713
70.366
158.639
Equity
26.987
68.950
127.020
Long-term debt
0
0
0
Short-term debt
1.726
1.416
31.620
Total debt
1.726
1.416
31.620
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-5212218800.0%
This company
2022
2024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
2022
2024
Return on equity
-29.1%
This company
18.4%
Market median
-258% vs market
2022
2024
Net profit margin (of gross profit)
-3702093300.0%
This company
2022
2024
Asset turnover (of gross profit)
-0.33×
This company
2022
2024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-09-28 – 2022-12-31
View
PDF
More on Orbis Medicines ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
